Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 2022677
PUBLISHER: BCC Research | PRODUCT CODE: 2022677
2025 Diagnostics Research Review
PUBLISHED:
PAGES: 277 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for human microbiome-based drugs and diagnostics was valued at $315.2 million in 2024 and is expected to reach $1.2 billion by the end of 2030, at a CAGR of 25.6% from 2025 to 2030.
The global market for molecular diagnostics was valued at $20.3 billion in 2024 and is expected to reach $42.6 billion by the end of 2030, at a CAGR of 13.1% from 2025 to 2030.
The global market for noninvasive cancer diagnostics was valued at $112.8 billion in 2024 and is projected to reach $165.2 billion by the end of 2030, at a CAGR of 6.6% from 2025 to 2030.
Report Scope
The diagnostics industry has grown despite the challenging economic conditions in recent years. The industry draws much attention and scrutiny from the public and government, and is currently undergoing many changes due to increased focus on regulations. These changes can be seen across many countries. The U.S., the largest diagnostics market, is leading the trend with changes intended to make healthcare more affordable. Opportunities for the diagnostics industry are manifold, with the appearance of new markets located mainly in emerging economies with varying needs.
Increasing healthcare expenditures and the growth of emerging economies have increased the demand for technologically better diagnostic devices, kits, reagents, and other accessories. Additionally, the introduction of more stringent regulations, specifically in the developed markets of the U.S. and Europe, has forced diagnostics manufacturers to launch advanced products that include new materials, a focus on in-depth indications, and the ability to produce additional new data.
Some of the major driving factors in the market are the increasing prevalence of chronic and infectious diseases, technological advances in diagnostics, increasing investments in AI in the diagnostics market, increased applications in non-oncology areas, and growing adoption of personalized medicine.
Furthermore, technically sophisticated diagnostics are needed for clinical research, as the market is highly competitive, and companies must continuously reinvent their product portfolios to enter new markets and place themselves as key participants in the healthcare system. There is a shift toward a value-based healthcare market where price and purchase decisions are based on outcomes. This has further led to increased scrutiny of device technology, and consequently, the degree of competition has risen. Some of the major firms in the diagnostics market include Abbott, Medtronic, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Agilent Technologies Inc., QIAGEN, Danaher Corp., Sysmex, Thermo Fisher Scientific Inc., BD, and others.
The diagnostics industry is a multi-billion-dollar market with an outlook for continued growth in the coming years. Hospital care is growing, and the diagnostics industry is being looked at to provide low-cost technology for home healthcare. Now, the industry seeks healthcare diagnostic devices, kits, and reagents that individuals with unskilled healthcare experience can use. The need for modern technology, equipment, and devices can be leveraged through diagnostic equipment as manufacturers seek to create better-quality healthcare solutions.
The above reasons are compelling enough to analyze and research the diagnostics market, as the market has tremendous growth potential.
It includes highlights from these reports published in 2024:
MDS051B Tissue Diagnostics: Technologies and Global Markets
- HLC300A Global Colorectal Cancer Screening and Diagnostics Market
- MDS046B Oncology Diagnostics: Global Markets
- BIO150E Liquid Biopsy Research Tools, Services, and Diagnostics
- BIO151B Human Microbiome-based Drugs and Diagnostics
- BIO063F Molecular Diagnostics: Technologies and Global Markets
- HLC186D In Vitro Diagnostics: Technologies and Global Markets
- PHM026D Global Markets for Allergy Diagnostics and Treatments
- HLC197B Noninvasive Cancer Diagnostics: Technologies and Global Markets
- HLC029G Global Markets for Diabetes Therapeutics and Diagnostics
After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.
Product Code: BIO263B
Table of Contents
Chapter 1 Foreword
- Research Review Scope
Chapter 2 Tissue Diagnostics: Technologies and Global Markets (MDS051B)
- Market Outlook
- Scope of Report
- Market Summary
- Market Overview and Definitions
- Immunohistochemistry (IHC)
- In Situ Hybridization
- Polymerase Chain Reaction
- Next-Generation Sequencing
- General Culture Testing
- Market Dynamics
- Market Drivers
- Market Opportunities
- Market Restraints
- Market Challenges
- Emerging Technologies and Developments
- Market Breakdown
- Market Breakdown by Product Type
- Market Breakdown by Segment
- Histopathology Market
- Molecular Pathology Market
- Microbiology Testing Market
- Digital Pathology Market
- Market Breakdown by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Rest of the World
- Sustainability in the Market for Tissue Diagnostics: An ESG Perspective
- Introduction to ESG
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC
Chapter 3 Global Colorectal Cancer Screening and Diagnostics Market (HLC300A)
- Market Outlook
- Scope of Report
- Market Insights
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
- Market Analysis by Test Type
- Colonoscopy and Sigmoidoscopy Tests
- Stool DNA Tests
- Blood-Based/Biomarker Tests
- Fecal Occult Blood Tests (FOBT)
- Fecal Immunochemical Tests (FIT)
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market
- Introduction
- Sustainability
- Concluding Remarks from BCC
Chapter 4 Oncology Diagnostics: Global Markets (MDS046B)
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Strategic Initiatives
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Opportunities
- Market Restraints
- Market Challenges
- Emerging Technologies
- Global Market Insights
- Market Breakdown by Product Type
- Diagnostics Imaging
- Endoscopy Devices
- Tumor Biomarker Tests
- Biopsy Devices
- Hematoxylin and Eosin
- Immunohistochemistry
- In situ Hybridization
- Polymerase Chain Reaction
- Next-Generation Sequencing
- Others
- Market Breakdown by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa (MEA)
- Sustainability in the Market for Oncology Diagnostics: An ESG Perspective
- Introduction to ESG
- ESG Performance Analysis
- Concluding Remarks from BCC
Chapter 5 Liquid Biopsy Research Tools, Services and Diagnostics (BIO150E)
- Market Outlook
- Scope of Report
- Market Summary
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Market Trends
- Global Market for Liquid Biopsy by Application
- Non-invasive Prenatal Testing (NIPT)
- Cancer
- Organ Transplantation
- Global Market for Liquid Biopsy by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
- Sustainability in the Liquid Biopsy Market: ESG Perspective
- Introduction to ESG
- ESG Practices in the Liquid Biopsy Industry
- Environmental Performance
- Social Performance
- Governance Performance
- ESG Risk Ratings
- Concluding Remarks from BCC Research
Chapter 6 Human Microbiome-based Drugs and Diagnostics (BIO151B)
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics
- Emerging Technologies
- Analysis by Segment
- Regional Analysis
- Conclusion
- Overview and Market Definition
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Market Analysis by Type
- Microbiome-based Drugs
- Microbiome-based Diagnostics
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Sustainability in the Human Microbiome-based Drugs and Diagnostics Industry: An ESG Perspective
- Introduction to ESG
- ESG Risk Ratings
- Concluding Remarks
Chapter 7 Molecular Diagnostics: Technologies and Global Markets (BIO063F)
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Market Analysis by Technology
- Key Takeaways
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
- In Situ Hybridization
- Microarrays
- Others
- Market Analysis by Product and Service
- Key Takeaways
- Consumables
- Instruments
- Software and Services
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Sustainability in the Molecular Diagnostics Market: An ESG Perspective
- Introduction to ESG
- ESG Practices in the Molecular Diagnostics Industry
- ESG Risk Ratings
- Conclusion
Chapter 8 In Vitro Diagnostics: Technologies and Global Markets (HLC186D)
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies in the IVD Market
- Market Analysis by Technology
- Immunochemistry
- POC Testing
- Hematology
- Molecular Diagnostics
- Tissue Diagnostics
- Clinical Microbiology
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
- Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
- Importance of ESG in In Vitro Diagnostics Manufacturing Industry
- ESG Practices in the In Vitro Diagnostics Industry
- Environmental Performance
- Social Performance
- Governance Performance
- Company Role in ESG Development
- ESG Risk Ratings
- BCC Research Viewpoint
Chapter 9 Global Markets for Allergy Diagnostics and Treatments (PHM026D)
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Segmental Analysis
- Regional Analysis
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Emerging Technologies
- Global Allergy Diagnostics and Treatment Market by Type
- Key Takeaways
- Diagnostics
- Treatments
- Global Allergy Diagnostics and Treatment Market by Drug Type
- Key Takeaways
- Prescription Drugs
- Over-the-Counter Drugs
- Global Allergy Diagnostics and Treatment Market by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa (MEA)
- South America
- Sustainability in the Allergy Diagnostics and Treatment Market:ESG Perspective
- Introduction to ESG
- Role of ESG in the Allergy Diagnostics and Treatment Market
- ESG Risk Ratings
- Conclusion
Chapter 10 Noninvasive Cancer Diagnostics: Technologies and Global Markets (HLC197B)
- Market Outlook
- Scope of the Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
- Current Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
- Emerging Technologies
- Market Analysis by Cancer Type
- Key Takeaways
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Cervical Cancer
- Stomach Cancer
- Liver Cancer
- Esophageal Cancer
- Bladder Cancer
- All Other Cancers
- Market Analysis by Technology Type
- Key Takeaways
- Diagnostic Imaging Technologies
- Advanced Noninvasive Approaches
- Conventional Noninvasive Cancer Screening, Diagnostic Assays and Tests
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
- Sustainability in Global Noninvasive Cancer Diagnostics Market: An ESG Perspective
- Introduction to ESG
- Major Manufacturers: ESG Efforts
- Concluding Remarks from BCC Research
Chapter 11 Global Markets for Diabetes Therapeutics and Diagnostics (HLC029G)
- Market Outlook
- Scope of Report
- Market Summary
- Overview
- Current Market Scenario
- Segmental Analysis
- Technological Advances
- Conclusion
- Market Overview
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Challenges
- Emerging Technologies
- Global Diabetes Therapeutics and Diagnostic Market by Product
- Key Takeaways
- Diabetes Therapeutics
- Diabetes Monitoring Devices and Accessories
- Insulin Delivery Devices
- Global Diabetes Therapeutics and Diagnostic Market by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
- Sustainability in the Diabetes Therapeutics and Diagnostics Market: An ESG Perspective
- Introduction to ESG
- ESG in Diabetes Therapeutics and Diagnostics
- ESG Performance Analysis
- Concluding Remarks from BCC
Chapter 12 Appendix
- Methodology
- Analyst's Credentials
Product Code: BIO263B
List of Tables
- Table 1 : Global Tissue Diagnostics Market, by Product Type, Through 2029
- Table 2 : Global Incidence of All Cancers, by Region, 2022-2045
- Table 3 : Cancer Cases, by Country, 2022
- Table 4 : Incidence of Cancer, by Cancer Type, 2022
- Table 5 : Global Tissue Diagnostics Market, Through 2029
- Table 6 : Global Tissue Diagnostics Market, by Product Type, Through 2029
- Table 7 : Global Tissue Diagnostics Market, by Segment Type, Through 2029
- Table 8 : Global Tissue Diagnostics Market, by Region, Through 2029
- Table 9 : ESG: Environmental Overview
- Table 10 : ESG: Social Overview
- Table 11 : ESG: Governance Overview
- Table 12 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
- Table 13 : Countries with Highest Colorectal Cancer Incidence and Rates, 2022
- Table 14 : Successful Colorectal Cancer Screening Initiatives, 2004-2011
- Table 15 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029
- Table 16 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
- Table 17 : Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
- Table 18 : Recent ESG Highlights from Select Testing Services Providing Companies
- Table 19 : ESG Rankings for a Few Service-Providing Companies, 2024
- Table 20 : ESG Rankings for Major Product Manufacturing Companies, 2024
- Table 21 : Global Market for Oncology Diagnostics, by Product Type, Through 2029
- Table 22 : Cancer Treatments Based on Specific Tests
- Table 23 : Select FDA-Approved AI-Associated/Associable-Equipped Medical Devices
- Table 24 : Global Oncology Diagnostics Market, by Product Type, Through 2029
- Table 25 : Global Oncology Diagnostics Market, by Region, Through 2029
- Table 26 : ESG: Environmental Overview
- Table 27 : ESG: Social Overview
- Table 28 : ESG: Governance Overview
- Table 29 : Global Market for Liquid Biopsy, by Region, Through 2029
- Table 30 : Liquid Biopsy Sample Types and Characteristics
- Table 31 : Global Market for Liquid Biopsy, by Application, Through 2029
- Table 32 : Global Market for Liquid Biopsy, by Region, Through 2029
- Table 33 : Key Focus Areas in ESG Metrics
- Table 34 : Environmental Performance Initiatives in the Liquid Biopsy Market
- Table 35 : Social Performance Initiatives in the Liquid Biopsy Market
- Table 36 : Governance Performance Initiatives in the Liquid Biopsy Market
- Table 37 : ESG Rankings for Leaders in the Market for Liquid Biopsy, 2024*
- Table 38 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
- Table 39 : Diseases Associated with Microbiome Dysbiosis
- Table 40 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Type, Through 2030
- Table 41 : Global Market for Human Microbiome-based Drugs and Diagnostics, by Region, Through 2030
- Table 42 : ESG Goals of Human Microbiome-based Drugs and Diagnostics Companies
- Table 43 : ESG Risk Ratings for Human Microbiome-based Drugs and Diagnostics Firms, 2025
- Table 44 : Global Molecular Diagnostics Market, by Region, Through 2030
- Table 45 : Global Molecular Diagnostics Market, by Technology, Through 2030
- Table 46 : Global Molecular Diagnostics Market, by Product and Service, Through 2030
- Table 47 : Global Molecular Diagnostics Market, by Region, Through 2030
- Table 48 : Environmental Performance Initiatives in the Molecular Diagnostics Market
- Table 49 : Social Performance Initiatives in the Molecular Diagnostics Market
- Table 50 : Governance Performance Initiatives in the Molecular Diagnostics Market
- Table 51 : ESG Risk Rankings for Molecular Diagnostics Companies, 2025
- Table 52 : Global Market for In Vitro Diagnostics, by Region, Through 2029
- Table 53 : Global Market for In Vitro Diagnostics, by Technology, Through 2029
- Table 54 : Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
- Table 55 : Global Market for In Vitro Diagnostics, by Region, Through 2029
- Table 56 : ESG Practices: Environmental Performance
- Table 57 : ESG Practices: Social Performance
- Table 58 : ESG Practices: Governance Performance
- Table 59 : Creating an Attractive Workplace: Social Performance
- Table 60 : ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
- Table 61 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
- Table 62 : Global Market for Allergy Diagnostics and Treatment, by Type, Through 2030
- Table 63 : Global Market for Allergy Diagnostics and Treatment, by Drug Type, Through 2030
- Table 64 : Global Market for Allergy Diagnostics and Treatment, by Region, Through 2030
- Table 65 : ESG Risk Rankings for Allergy Diagnostic and Treatment Market Companies, 2025*
- Table 66 : Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
- Table 67 : Types of Liquid Biopsy and Their Clinical Applications, 2024
- Table 68 : Estimated Cancer Incidence, Age (0-85+), 2022-2045
- Table 69 : Estimated Cancer Incidence in Males in the U.S., by Cancer Site, 2025
- Table 70 : Estimated Cancer Incidence in Females in the U.S., by Cancer Site, 2025
- Table 71 : Global Market for Noninvasive Cancer Diagnostics, by Cancer Type, Through 2030
- Table 72 : Global Market for Noninvasive Cancer Diagnostics, by Technology Type, Through 2030
- Table 73 : Global Market for Noninvasive Cancer Diagnostics, by Region, Through 2030
- Table 74 : ESG Highlights, by Major Players, 2024
- Table 75 : Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
- Table 76 : Indonesia: Price Ranges of Diabetes Monitoring Products, by Sector, 2024
- Table 77 : Selected Technology Integrated Products
- Table 78 : Global Market for Diabetes Therapeutics and Diagnostics, by Product, Through 2030
- Table 79 : Global Revenues of Leading Diabetes-Focused Pharmaceutical Companies,2023 and 2024
- Table 80 : Major Companies: Diabetes Therapeutic Pipeline
- Table 81 : Insulin vs. GLP-1 Therapy
- Table 82 : Standard GLP-1 RAs vs. Dual/Triple Agonists
- Table 83 : Comparison of Different Types of Insulins
- Table 84 : Oral Antidiabetic Drugs Overview
- Table 85 : Blood Glucose Test Strips, by Manufacturer
- Table 86 : Blood Glucose Meters, by Manufacturer
- Table 87 : Continuous Glucose Monitoring Systems, by Manufacturer
- Table 88 : Comparison of Continuous Glucose Monitoring Systems, by Company
- Table 89 : Lancets and Lancet Devices, by Manufacturer
- Table 90 : Insulin Infusion Pumps, by Manufacturer
- Table 91 : Insulin Pen, by Manufacturer
- Table 92 : Global Market for Diabetes Therapeutics and Diagnostics, by Region, Through 2030
- Table 93 : Diabetes Waste Management Recommendations
- Table 94 : ESG Rankings for Diabetes Therapeutics and Diagnostics Companies, 2025*
- Table 95 : ESG: Environmental Overview
- Table 96 : ESG: Social Overview
- Table 97 : ESG: Governance Overview
List of Figures
- Figure 1 : Shares of Global Market for Tissue Diagnostics, by Product Type, 2023
- Figure 2 : Shares of All Cancer Cases, by Region, 2022
- Figure 3 : Shares of Global Market for Tissue Diagnostics, by Segment Type, 2023
- Figure 4 : Shares of Global Market for Tissue Diagnostics, by Region, 2023
- Figure 5 : ESG Pillars
- Figure 6 : Advantages of ESG for Companies
- Figure 7 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
- Figure 8 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, 2023
- Figure 9 : Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
- Figure 10 : Snapshot of ESG Pillars
- Figure 11 : Global Market Shares of Oncology Diagnostics, by Product Type, 2023
- Figure 12 : Number of FDA-Approved Companion Diagnostic Devices, 1997-2024
- Figure 13 : Share of Global Market for Oncology Diagnostics, by Product Type, 2023
- Figure 14 : Share of Global Market for Oncology Diagnostics, by Region, 2023
- Figure 15 : ESG Pillars
- Figure 16 : Advantages of ESG for Companies
- Figure 17 : Global Market Shares of Liquid Biopsy, by Application 2024
- Figure 18 : Estimated Number of New Cancer Cases Globally, 2022, 2045 and 2050
- Figure 19 : Global Market Shares of Liquid Biopsy, by Region, 2024
- Figure 20 : How a Strong ESG Proposition Benefits Businesses?
- Figure 21 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Region, 2024
- Figure 22 : Diseases and Conditions Associated with Dysbiosis
- Figure 23 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Type, 2024
- Figure 24 : Global Market Shares of Human Microbiome-based Drugs and Diagnostics, by Region, 2024
- Figure 25 : Global Molecular Diagnostics Market Shares, by Region, 2024
- Figure 26 : Global Molecular Diagnostics Market Shares, by Technology, 2024
- Figure 27 : Global Molecular Diagnostics Market Shares, by Product and Service, 2024
- Figure 28 : Global Molecular Diagnostics Market Shares, by Region, 2024
- Figure 29 : Key ESG Metrics of Molecular Diagnostics Companies
- Figure 30 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
- Figure 31 : Emerging AI Applications in In Vitro Diagnostics
- Figure 32 : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
- Figure 33 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
- Figure 34 : SNAPSHOT: Key ESG Trends in the In Vitro Diagnostics Industry
- Figure 35 : Global Market Shares of Allergy Diagnostic and Treatments, by Region, 2024
- Figure 36 : Global Market Shares of Allergy Diagnostics and Treatment, by Type, 2024
- Figure 37 : Global Market Shares of Allergy Diagnostics and Treatment, by Drug Type, 2024
- Figure 38 : Global Market Shares of Allergy Diagnostics and Treatment, by Region, 2024
- Figure 39 : Pillars of ESG
- Figure 40 : Advantages of ESG for Companies
- Figure 41 : Global Market Shares for Noninvasive Cancer Diagnostics, by Region, 2024
- Figure 42 : Global Market Shares for Noninvasive Cancer Diagnostics, by Cancer Type, 2024
- Figure 43 : Global Market Shares for Noninvasive Cancer Diagnostics, by Technology Type, 2024
- Figure 44 : Global Market Shares for Noninvasive Cancer Diagnostics, by Region, 2024
- Figure 45 : Pillars of Sustainable Cancer Care
- Figure 46 : :Global Market Shares for Diabetes Therapeutics and Diagnostics, by Region, 2024
- Figure 47 : DIABETES: Type
- Figure 48 : Estimated Number of People Aged 20 to 79 With Diabetes, Globally, 2000-2024
- Figure 49 : Global Market Shares for Diabetes Therapeutics and Diagnostics, by Product, 2024
- Figure 50 : Global Market Shares for Diabetes Therapeutics and Diagnostics, by Region, 2024
- Figure 51 : ESG Pillars
- Figure 52 : Advantages of ESG for Companies
- Figure 53 : Diabetes Therapeutics and Diagnostics: Key ESG Issues
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.